Metrics raised 5
- FY27 adjusted EBITDA: guided to full-year consolidated profitability with >40% YoY improvement (FY26: -₹105 crores; Q4 FY26 marked first breakeven quarter)
- FY30 service EBITDA margin: 24-25% (from ~13-14% today)
- FY30 corporate overheads as % of revenue: below 5-6% (from 23% in FY26)
- FY30 adjusted EBITDA margin: 18-20% (from ~-10% in FY26)
- Long-term (~5 years) PAT before exceptional items margin: 17-20% of revenue (from ~12% in FY26)
Event Participants
Executives
4
Anand Rohidas Prabhudesai, Badrinarayan Sanjeevi, Dhirendra Nalin Mahyavanshi, Nitin Garewal
Analysts
9
Divyansh Jaju, Mokshit, Nidhesh Jain, Nischint Chawathe, Prayesh Jain, Rahil Bharat Shah, Satvik Kanabar, Shubham Karvande, Shubham Prajapati
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Platform Premium (FY26) | ₹3,868 crores | +31% YoY from ₹2,946 crores; PoSP-led premium grew 40%+; health was the fastest-growing category |
| Operating Revenue (FY26) | ₹1,098 crores | +57% YoY from ₹700 crores; one of the strongest growth years; Q4 grew 42% - closer to steady state |
| Q4 FY26 Operating Revenue | ₹357 crores | +42% YoY; seasonally strongest quarter of the year |
| Renewal Revenue (FY26) | ₹225 crores | +51% YoY; ~20% of total revenue; renewal service EBITDA 2.5-3x new business |
| Service EBITDA (FY26) | ₹142 crores | +70% YoY; margin ~13% of revenue; driven by renewal book growth and 20%+ frontline productivity gains |
| Q4 FY26 Service EBITDA | ₹60 crores | +60% YoY |
| Adjusted EBITDA (FY26) | -₹105 crores | Improved from -₹186 crores FY25 (-10% vs -27% of revenue); Q4 marked first-ever consolidated breakeven quarter |
| PAT before Exceptional Items (FY26) | ₹129 crores | vs -₹203 crores FY25; ~12% of revenue; includes ₹25 crores ESOP cost (2.3% of revenue); Q4 PAT positive |
| Corporate Overheads (FY26) | ₹247 crores | Down from ~₹270 crores FY25; 23% of revenue vs 38% FY25; 16% in Q4; held in ₹230-260 crore band for 4 years |
| P3M Active Digital Partners | 93,000+ | As of Mar 31, 2026; 51% CAGR over 7 years; FY26 quarterly average ~84,000 |
| Verified Digital Partners | 6.5 lakh+ | 41% CAGR since FY20; top 100 DPs contribute just 4.62% of platform premium |
| Cash Conversion | 99% | PAT-to-CFO conversion; receivables ₹150-160 crores (~40-50 days); PoSP payouts largely post-collection |
| Exceptional Items | ₹55 crores | Non-cash charge from preference-to-equity conversion (9M FY26 only); none in Q4, none expected FY27 |
Geographic & Segment Commentary
- PoSP-led Insurance Distribution (Turtlemint Insurance Broking): Premium grew 40%+ YoY, powered by 93,000+ P3M active digital partners spanning 19,000+ PIN codes (98-99% of the country). 76% of platform premium originates beyond the top 30 cities, with top 100 DPs contributing only 4.62% - a highly granular, last-mile network.
- Health Insurance: Fastest-growing category at 75%+ YoY per CEO (CFO cited 60%+), benefiting from improved affordability post-GST rate cuts; strategically important given higher renewal rates and service EBITDA contribution.
- Turtlefin (Enterprise Distribution): ~20% of platform premium; low-take-rate technology licensing model but high margin since tech is pre-built; multiple new enterprise accounts signed in FY26 are expected to go live in FY27, accelerating growth.
- Non-Insurance Adjacencies (Mutual Funds & Loans): ~3% of FY26 revenue; mutual fund AUM ~₹1,400 crores; loan disbursement run-rate ~₹300 crores annualized; incremental revenue largely drops directly into EBITDA.
- Renewal Book: ~20% of revenue (₹225 crores, +51% YoY); renewal rates above industry average across product categories due to granular PoSP base and near-100% policyholder contactability.
Company-Specific & Strategic Commentary
- RAP Engine (Recruit-Activate-Produce): Core growth moat; 80% of DPs are new to insurance (most under 35, spanning 60-65 occupation profiles), onboarded digitally via app plus pan-India offline branches; FY20 cohort now earns 3.8x its initial income on the platform.
- Digital Partner Ecosystem: Turtlemint Pro app crossed 5 million downloads (highest among insurance seller apps, 4.5-star rating); 8 lakh+ quotes generated daily; 1.25M+ localized content pieces shared monthly in 8 regional languages; Turtlemint Academy has 52,000+ monthly active users consuming 6,500+ training hours/month, certifying 5,000+ new sellers monthly.
- AI & Automation: Agentic AI being deployed across AI-first support tickets, automated renewal nudges (improving renewal rates on small-ticket policies), and claims support; Ninja Sales Pro CRM drives 20%+ annual frontline productivity gains; Insurance Hub enables 100% paperless policy issuance across 40+ insurers.
- Claims Support: In-house expert claims desk (in-house doctor for health, ex-surveyors for GI) resolved ₹85+ crores of delayed/rejected claims in Q4 FY26 via app-based tracking and direct insurer engagement.
- Operating Leverage: Corporate overheads held flat in a ₹230-260 crore band for four years while revenue scaled nearly 3x; Q4 overheads at 16% of revenue - key driver of first-ever adjusted EBITDA breakeven quarter.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| FY27 Adjusted EBITDA | Full-year profitability on consolidated basis | Q4 FY26 marked first breakeven quarter; management expects profitability to improve >40% YoY as done historically; quarterly seasonality (each quarter larger than prior) means non-linear path, Q4 seasonally largest |
| Revenue / Premium Growth | Continue historical 40%+ CAGR; no formal guidance | Board decided against formal guidance; Q4 growth (~42%) is closer to steady state, with H1 FY26 benefiting from base effects |
| 5-Year Margin Framework (FY30) | Service EBITDA 24-25%; corporate overheads sub 5-6% of revenue; adjusted EBITDA 18-20% | Expansion from 13-14% service EBITDA today, led by compounding renewal book and flat fixed costs |
| Long-Term PAT Margin (~5 years) | 17-20% of revenue | PBT/PAT level; led by service EBITDA expansion while corporate overheads held relatively flat |
| ESOP Cost | Significant reduction by FY28 | FY26 included a larger grant; accounting estimates for grants up to FY26 decline meaningfully by FY28 |
| Exceptional Items | None in Q4 FY26 or FY27 | ₹55 crores one-time non-cash charge (preference-to-equity conversion) recorded only in 9M FY26 |
Risks & Constraints
| Risk | Context |
|---|---|
| Commission Regulation Changes | IRDAI's ongoing commission structure review could compress distributor payouts; PoSP classification (agent vs broker) remains uncertain. Management argues the asset-light, post-transaction cost model absorbed the GST-cut commission reductions and still delivered 75%+ health growth; platform can pass down commercial changes. |
| Product Mix Concentration | General insurance (led by health and motor) is >90% of revenue; management declined to disclose motor/health premium splits, limiting visibility into mix-driven margin swings. |
| Renewal Rate Dependency | Margin expansion hinges on continued renewal-rate improvement; AI-led nudges and granular contactability support this, but a persistency deterioration would pressure service EBITDA. |
| Seasonality of Profitability | Q4 is seasonally the largest quarter; FY27 profitability will be weighted to H2, with Q1 typically weakest - full-year profitability assumes historical seasonality holds. |
| Enterprise (Turtlefin) Ramp Dependency | ~20% of platform premium depends on enterprise partners' go-live timelines and digitization pace; FY27 growth acceleration is contingent on new accounts ramping. |
| Competitive Intensity | Established players (e.g., Policybazaar) and potential AI-driven disintermediation; management views the advisory-led, last-mile model as defensible but competition for DP recruitment remains intense. |
Q&A Highlights
Growth Drivers & Sustainability
- Question: What drove FY26's strong premium/revenue growth beyond GST tailwinds, and is it sustainable given H2 FY27 base effects? (Prayesh Jain)
- Answer: Growth is driven by the RAP engine - existing cohorts improve productivity YoY while new cohorts add volume, compounded by renewal book build; health insurance grew 75%+ on improved affordability post-GST. Q4 growth (~42%) is closer to steady state; the company has historically grown 40%+ across revenue and key KPIs (Dhirendra Mahyavanshi).
Commission Regulation & PoSP Classification
- Question: If commissions are cut, can Turtlemint pass through the impact? Will PoSPs be treated as agents or brokers under new regulations? (Prayesh Jain)
- Answer: The model is asset-light and performance-driven - costs are incurred only post-transaction, so the platform absorbs volatility and passes down changes; when GST cuts reduced commissions, payouts were passed down and health volumes still grew 75%+. PoSPs are micro-entrepreneurs driving B30 penetration; adding product supply sustains volumes. Regulatory classification is speculative at this point (Dhirendra Mahyavanshi).
Digital Partner Recruitment Moat
- Question: How does Turtlemint recruit such a large number of DPs amid high competition, and how big is the TAM? (Satvik Kanabar)
- Answer: 80% of DPs come from non-insurance backgrounds (most under 35, spanning 60-65 profiles); onboarding is digital via the app plus pan-India offline branch presence; customized training paths via Turtlemint Academy activate them at scale; network spans 19,000+ PIN codes including the remotest parts of the country (Dhirendra Mahyavanshi).
AI Initiatives & Cost Savings
- Question: What role does AI play, are there cost savings, and could AI potentially disrupt the business model? (Satvik Kanabar)
- Answer: Agentic AI/LLM automations target human-to-human touchpoints - support tickets are AI-first with human fallback; automated renewal reminder calls (especially for small-ticket policies) are improving renewal rates; AI is a huge enabler for an advisory-led model, not a disruptor (Anand Prabhudesai).
FY27 Guidance & Profitability Path
- Question: Any guidance on FY27 revenue and OpEx growth? At what scale will EBITDA turn positive? (Satvik Kanabar; Divyansh Jaju)
- Answer: Board decided against formal guidance, but Q4 demonstrated operating leverage; FY27 should be profitable on a consolidated full-year basis with profitability improving >40% YoY as historically; each quarter is seasonally bigger than the prior, with Q4 the largest. Over five years, service EBITDA expands to 24-25% and corporate overheads to sub-5-6% of revenue, translating to 18-20% adjusted EBITDA (Dhirendra Mahyavanshi; Badrinarayan Sanjeevi).
Product Mix & Operating Leverage
- Question: How will product mix (life/health/motor) evolve and influence margins? At what level will adjusted EBITDA margins stabilize? (Shubham Prajapati)
- Answer: GI is >90% of revenue; health grew 60%+ and, with renewals, supports higher service EBITDA since renewal revenue (~20% of revenue) earns more. Corporate overheads stayed in a ₹230-260 crore band for four years while revenue scaled, driving operating leverage; PAT/PBT target of 17-20% of revenue in ~5 years (Badrinarayan Sanjeevi).
Claims Support & Working Capital Cycle
- Question: How involved is Turtlemint in the claims settlement process, and how has the working capital cycle evolved? (Shubham Karvande)
- Answer: In-house expert claims desk (in-house doctor for health, ex-surveyors for others) supports delayed/rejected claims with app-based status tracking;
₹85+ crores of such claims were settled in Q4. Working capital: receivables of ₹150-160 crores (40-50 days) supported by 15-day billing arrangements with many insurers; PoSP payouts are made largely after collections, keeping cash conversion at 99% (Dhirendra Mahyavanshi; Badrinarayan Sanjeevi).
Turtlefin Enterprise Business & Take Rates
- Question: Can you quantify enterprise premium and its growth outlook? How are take rates / insurer arrangements decided? (Rahil Bharat Shah)
- Answer: Turtlefin contributes ~20% of platform premium; take rate is low (technology fee, not broking commission) but high margin since tech is pre-built; new accounts signed in FY26 go live next year, expected to accelerate enterprise premium growth. Insurer agreements vary by value delivered - B30 reach, granular underwriting, low-cost scale, better loss ratios, and book quality (Anand Prabhudesai; Dhirendra Mahyavanshi).
Renewal vs New Business Margins & Non-Insurance Revenue
- Question: What is the service EBITDA differential between new and renewal business? What is the non-insurance revenue share? (Nidhesh Jain)
- Answer: Renewal service EBITDA is 2.5-3x new business service EBITDA. Non-insurance (Turtlefin tech fees, mutual funds, loans) is ~3% of FY26 revenue; mutual fund AUM ~₹1,400 crores, loan disbursement run-rate ~₹300 crores annualized - incremental revenue drops directly into EBITDA (Dhirendra Mahyavanshi; Badrinarayan Sanjeevi).
Motor Business & DP Product Migration
- Question: How large is the motor business, and how many DPs migrate beyond motor? (Nischint Chawathe)
- Answer: Most DPs start with two-wheeler policies and migrate to higher-end products like health; >60% of DPs operate across multiple product categories; 76% of premium comes from beyond top-30 cities. Management declined category-level GI premium splits for now; insurer concentration is low (top 3 ~22%) (Dhirendra Mahyavanshi; Badrinarayan Sanjeevi).
Competitive Positioning vs. Policybazaar
- Question: With insurance penetration at only 3-4%, what does Turtlemint do differently from larger distributors like Policybazaar? (Mokshit)
- Answer: Turtlemint is built on advisory-led, assisted distribution (95%+ of retail sales are assisted); its granular network of DPs reaches underserved Tier 3/4 markets via local-language awareness content, creating dialogue and trust; covering 98-99% of PIN codes positions it to drive the "Insurance for All by 2047" mission (Dhirendra Mahyavanshi).
Capital Allocation & Dividend Policy
- Question: With a large cash block and ~10% public shareholding, are buybacks or major capital decisions planned? (Mokshit)
- Answer: Management remains conservative on cash; after one or two years of sustained, strengthening profitability, the company will consider appropriate dividend/distribution policies; high operating leverage sets up the right ingredients for shareholder returns (Badrinarayan Sanjeevi).
Key Takeaway
Turtlemint delivered a strong FY26, with platform premium up 31% to ₹3,868 crores and operating revenue rising 57% to ₹1,098 crores; service EBITDA grew 70% to ₹142 crores (13% margin), while corporate overheads fell to 23% of revenue from 38%, producing a first-ever consolidated adjusted-EBITDA breakeven in Q4 and FY26 PAT before exceptional items of ₹129 crores at 99% cash conversion. Strategy centers on scaling the Recruit-Activate-Produce engine (93,000+ active DPs, 51% seven-year CAGR), deepening B30 penetration (76% of premium beyond top 30 cities), and deploying agentic AI across renewals, support, and claims - including ₹85+ crores of claims resolved in Q4. Management guided FY27 to full-year profitability with historical 40%+ growth, en route to 18-20% adjusted EBITDA margins over five years as renewal revenue (~20% of revenue, 2.5-3x new-business margin) compounds. Watch points include commission regulation changes, product-mix transparency, and the Turtlefin enterprise ramp.